![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences to Present At the Rodman & Renshaw 10th Annual Healthcare Conference On November 10, 2008
November 04, 2008 07:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences to Present At the Seventh Annual Bio(r) Investor Forum
October 22, 2008 07:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment
September 09, 2008 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Announces Second Quarter 2008 Results
August 11, 2008 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences to Present At the Canaccord Adams 28th Annual Global Growth Conference
August 07, 2008 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 7, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Announces Conference Call On Second Quarter Financial Results and Business Update
July 28, 2008 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 28, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, will announce its...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia
July 14, 2008 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 14, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Announces Schedule Change for Presentation At the Collins Stewart 4th Annual Growth Conference
July 07, 2008 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 7, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that,...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Presents Alocrest and Menadione Data At the European Society for Medical Oncology Conference
July 07, 2008 07:05 ET
|
Talon Therapeutics, Inc.
* Alocrest(tm) Phase 1 Data Demonstrates Potential for Improved Safety
and Efficacy Compared to Conventional Vinorelbine
* Menadione Topical Lotion Restores Kinase Activity and Does Not
...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences to Present At the Collins Stewart 4th Annual Growth Conference
July 02, 2008 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 2, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced that Steven R. Deitcher,...